What You Need to Know:
The American Medical Association (AMA) today released an upgrade to the Current Procedural Terminology (CPT ®) code set that includes brand-new code additions and editorial revisions for reporting medical services sparked by the public health action to the COVID-19 pandemic.
” Two of the freshly approved codes report nucleic acid assays that permit a single test to concurrently identify the unique coronavirus and a combination of typical viral contagious agents, including influenza A/B and respiratory syncytial virus,” stated AMA President Susan R. Bailey, M.D. “Concurrent detection promises to conserve crucial testing resources, enabling ongoing security of influenza while testing for the unique coronavirus.”
announces brand-new CPT codes for multi-virus tests to discover COVID-19 and influenza for
The upgrade to the CPT code set was approved by the CPT Editorial Panel, the independent body convened by the AMA with the authority to authorize and examine proposed additions and modifications to the CPT code set. The new additions and revisions to the CPT code set have been authorized for immediate use.
New CPT Codes
referral, the brand-new category I CPT codes and long descriptors are:
87636: Infectious representative detection by nucleic
acid (DNA or RNA); severe intense breathing syndrome coronavirus 2 (SARS-CoV-2).
( Coronavirus disease [COVID-19] and influenza infection types A and B, multiplex.
amplified probe technique.
87637: Infectious representative detection by nucleic.
acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
( Coronavirus illness [COVID-19], influenza virus types A and B, and.
breathing syncytial virus, multiplex magnified probe strategy.
CPT Editorial Panel Revisions.
The CPT Editorial Panel also revised CPT codes varying from 87301 to 87430 by getting rid of the undefined term “multi-step method” from code descriptors. The modification clarifies the proper reporting for antigen tests that are checked out by a machine, as compared to those which can be visually analyzed without a machine. This modification impacts the newly established descriptor for CPT code 87426.
87426: Infectious agent antigen detection by.
immunoassay method, (eg, enzyme immunoassay [EIA], enzyme-linked.
immunosorbent assay [ELISA], fluorescence immunoassay [FIA],. immunochemiluminometric assay [IMCA] qualitative or semiquantitative; severe.
intense respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19].
In accordance with the above revision, the CPT Editorial Panel approved a new category I code, 87811, to report contagious agent antigen detection by immunoassay with direct visual observation.
87811: Infectious agent antigen detection by.
immunoassay with direct optical (ie, visual) observation; severe acute.
respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus illness.
In addition to the long descriptors, brief and medium descriptors for CPT codes 87636, 87637, 87426 and 87811 can be accessed on the AMA site, in addition to numerous other current modifications to the CPT code set that have actually helped improve the general public health reaction to the SAR-CoV-2 infection and the COVID-19 disease.